Literature DB >> 20662635

Evaluation of species distribution and risk factors of candidemia: a multicenter case-control study.

Nur Yapar1, Husnu Pullukcu, Vildan Avkan-Oguz, Selda Sayin-Kutlu, Bulent Ertugrul, Suzan Sacar, Banu Cetin, Onur Kaya.   

Abstract

This study was planned to determine the risk factors of candidemia, and the most common Candida species causing bloodstream infections. A case-control study which included adult patients was conducted over a 1-year period at tertiary-care educational hospitals in Turkey. A total of 83 candidemia episodes were identified during the study period. Candida albicans was the most common species recovered (45.8%) followed by Candida tropicalis (24.1%) Candida parapsilosis (14.5%) and Candida glabrata which was isolated from only four (4.8%) patients. Presence of a urethral catheter (odds ratio [OR] 2.38; 95% confidence interval [CI] 1.09-5.19; P = 0.02), previous use of antibiotics (OR 2.61; 95% CI 1.05-6.46; P = 0.03), RBC transfusions (OR 2.14; 95% CI 1.16-3.94; P = 0.01) and parenteral nutrition (OR 4.44; 95% CI 2.43-8.11; P < 0.01) were found as independent risk factors for candidemia. TPN (Total Parenteral Nutrition) was an independent risk factor for both C. albicans and non-Candida albicans Candida species (P < 0.001). Most of the risk factors were invasive procedures and former medications. We conclude that a great number of candidemia cases are preventable by means of reduction of unnecessary invasive procedures and the use of antimicrobials.

Entities:  

Mesh:

Year:  2010        PMID: 20662635     DOI: 10.3109/13693786.2010.501344

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  17 in total

1.  Antifungal Susceptibility and Risk Factors in Patients with Candidemia.

Authors:  Cigdem Mermutluoglu; Ozcan Deveci; Saim Dayan; Emel Aslan; Fatma Bozkurt; Recep Tekin
Journal:  Eurasian J Med       Date:  2016-10

2.  Pharmacoeconomic evaluation of micafungin versus caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in Turkey.

Authors:  C F Neoh; E Senol; A Kara; E C Dinleyici; S J Turner; D C M Kong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-11-28       Impact factor: 3.267

3.  Risk factors for candidemia in pediatric intensive care unit patients.

Authors:  Hasan Ağın; Ilker Devrim; Rana Işgüder; Utku Karaarslan; Esra Kanık; Ilker Günay; Miray Kışla; Sultan Aydın; Gamze Gülfidan
Journal:  Indian J Pediatr       Date:  2014-03-14       Impact factor: 1.967

4.  Factors Influencing Non-albicans Candidemia: A Case-Case-Control Study.

Authors:  Diamantis P Kofteridis; Antonis Valachis; Dimitra Dimopoulou; Angeliki M Andrianaki; Athanasia Christidou; Sofia Maraki; Nikolaos A Spernovasilis; George Samonis
Journal:  Mycopathologia       Date:  2017-05-19       Impact factor: 2.574

5.  Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey.

Authors:  Murat Kutlu; Selda Sayın-Kutlu; Sema Alp-Çavuş; Şerife Barçın Öztürk; Meltem Taşbakan; Betil Özhak; Onur Kaya; Oya Eren Kutsoylu; Şebnem Şenol-Akar; Özge Turhan; Gülşen Mermut; Bülent Ertuğrul; Hüsnü Pullukcu; Çiğdem Banu Çetin; Vildan Avkan-Oğuz; Nur Yapar; Dilek Yeşim-Metin; Çağrı Ergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-27       Impact factor: 3.267

6.  Retrospective evaluation of candidemic patients among general surgery department in a tertiary care university hospital.

Authors:  Uğur Önal; Dilek Yeşim Metin; Can Karaca; Süleyha Hilmioğlu Polat; Sinan Ersin; Meltem Işıkgöz Taşbakan
Journal:  Turk J Surg       Date:  2019-09-23

7.  Synergistic antifungal activity of berberine derivative B-7b and fluconazole.

Authors:  Li Ping Li; Wei Liu; Hong Liu; Fang Zhu; Da Zhi Zhang; Hui Shen; Zheng Xu; Yun Peng Qi; Shi Qun Zhang; Si Min Chen; Li Juan He; Xin Ju Cao; Xin Huang; Jun Dong Zhang; Lan Yan; Mao Mao An; Yuan Ying Jiang
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

Review 8.  Epidemiology and risk factors for invasive candidiasis.

Authors:  Nur Yapar
Journal:  Ther Clin Risk Manag       Date:  2014-02-13       Impact factor: 2.423

9.  The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.

Authors:  Hao Wang; Naizheng Liu; Mei Yin; Hui Han; Jinfeng Yue; Fan Zhang; Tichao Shan; Haipeng Guo; Dawei Wu
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

10.  Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil: study in the period 2007-2010.

Authors:  Vanessa Kummer Perinazzo Oliveira; Luciana da Silva Ruiz; Nélio Alessandro Jesus Oliveira; Débora Moreira; Rosane Christine Hahn; Analy Salles de Azevedo Melo; Angela Satie Nishikaku; Claudete Rodrigues Paula
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jul-Aug       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.